ОБЗОР
МЕЖДУНАРОДНЫХ
ПЕРИОДИЧЕСКИХ
ИЗДАНИЙ

НОВОСТИ СВЕЖИЙ НОМЕР ОБ ИЗДАНИИ
Для специалистов по репродуктивному здоровью. PROdigest. Приложение к бюллетеню
prodigest prodigest prodigest prodigest prodigest
2015 vol1 2015 vol2 2015 vol3 2016 2017

Efficacy of Intrauterine infusion of granulocyte colony stimulating factor on patients with history of implantation failure: A randomized control trial.

Authors: Eftekhar M, Miraj S, Farid Mojtahedi M, Neghab N.
Publication date: 20170114
Journal: Int J Reprod Biomed (Yazd). 2016 Nov;14(11):687-690.

BACKGROUND:

Although pregnancy rate in in vitro fertilization-embryo transfer (IVF-ET) cycles has been increased over the preceding years, but the majority of IVF-ET cycles still fail. Granulocyte colony stimulating factor (GCSF) is a glycoprotein that stimulates cytokine growth factor and induces immune system which may improve pregnancy rate in women with history of implantation failure.

OBJECTIVE:

The aim of this study was to evaluate GCSF ability to improve pregnancy rate in women with history of implantation failure.

MATERIALS AND METHODS:

0.5 ml (300 µg/ml) GCSF was infused intrauterine in intervention group. Pregnancy outcomes were assessed based on clinical pregnancy.

RESULTS:

The mean age of participants was 31.95±4.71 years old. There were no significant differences between demographic characteristics in two groups (p>0.05). The pregnancy outcome in GCSF group was improved significantly (p=0.043).

CONCLUSION:

GCSF can improve pregnancy outcome in patients with history of implantation failure.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.